NALMEFENE



NAME OF DRUG : NALMEFENE

ALSO KNOWN AS : JKB121

LABORATORY : TaiwanJPharmaceuticals

STATUS AND ADVANCEMENT

Type of drug : Opioid receptor antagonists; Toll-like receptor 4 antagonists

Clinical trials advancement : Ongoing Phase 2a

Estimated time to market : 114 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON NALMEFENE

SOME PUBLICATIONS RELATED WITH NALMEFENE

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH NALMEFENE


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE